Fig. 8

JS-K inhibits the growth of rat primary hepatic carcinoma in vivo (n = 8). a The photographs of livers in control, DEN-treated and JS-K-treated groups. b-c IHC staining of PCNA and PP2A (200 × magnifcation) in control group, DEN group, and DEN+JS-K groups (0.25 mg/kg and 0.5 mg/kg). d The expression levels of PP2A-C, β-catenin, c-Myc and p-Bcl-2 in rat model of primary hepatic carcinoma were analyzed by western blot